Cargando…
Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer
Metabolic reprogramming is an emerging hallmark of cancer and is driven by abnormalities of oncogenes and tumor suppressors. Accelerated metabolism causes cancer cell aggression through the dysregulation of rate-limiting metabolic enzymes as well as by facilitating the production of intermediary met...
Autores principales: | Harachi, Mio, Masui, Kenta, Cavenee, Webster K., Mischel, Paul S., Shibata, Noriyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066013/ https://www.ncbi.nlm.nih.gov/pubmed/33916219 http://dx.doi.org/10.3390/metabo11040216 |
Ejemplares similares
-
Codependency of Metabolism and Epigenetics Drives Cancer Progression: A Review
por: Masui, Kenta, et al.
Publicado: (2020) -
GEN-14 Dual regulation of histone methylation by mTOR complexes drives the progression of EGFR-mutant glioblastoma
por: Masui, Kenta, et al.
Publicado: (2020) -
mTOR Complexes as a Nutrient Sensor for Driving Cancer Progression
por: Harachi, Mio, et al.
Publicado: (2018) -
The metabolomic landscape plays a critical role in glioma oncogenesis
por: Masui, Kenta, et al.
Publicado: (2022) -
mTORC2 dictates Warburg effect and drug resistance
por: Masui, Kenta, et al.
Publicado: (2014)